105 related articles for article (PubMed ID: 1895304)
1. Potential antitumor agents. 63. Structure-activity relationships for side-chain analogues of the colon 38 active agent 9-oxo-9H-xanthene-4-acetic acid.
Rewcastle GW; Atwell GJ; Baguley BC; Boyd M; Thomsen LL; Zhuang L; Denny WA
J Med Chem; 1991 Sep; 34(9):2864-70. PubMed ID: 1895304
[TBL] [Abstract][Full Text] [Related]
2. Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids.
Rewcastle GW; Atwell GJ; Li ZA; Baguley BC; Denny WA
J Med Chem; 1991 Jan; 34(1):217-22. PubMed ID: 1992120
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid.
Thomsen LL; Ching LM; Baguley BC
Cancer Res; 1990 Nov; 50(21):6966-70. PubMed ID: 2170013
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for substituted 9-oxo-9,10-dihydroacridine-4-acetic acids: analogues of the colon tumour active agent xanthenone-4-acetic acid.
Gamage SA; Rewcastle GW; Atwell GJ; Baguley BC; Denny WA
Anticancer Drug Des; 1992 Oct; 7(5):403-14. PubMed ID: 1388631
[TBL] [Abstract][Full Text] [Related]
5. Potential antitumor agents. 62. Structure-activity relationships for tricyclic compounds related to the colon tumor active drug 9-oxo-9H-xanthene-4-acetic acid.
Rewcastle GW; Atwell GJ; Palmer BD; Boyd PD; Baguley BC; Denny WA
J Med Chem; 1991 Feb; 34(2):491-6. PubMed ID: 1995870
[TBL] [Abstract][Full Text] [Related]
6. Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents.
Zwi LJ; Baguley BC; Gavin JB; Wilson WR
Oncol Res; 1994; 6(2):79-85. PubMed ID: 7949468
[TBL] [Abstract][Full Text] [Related]
7. Cytokine induction and therapeutic synergy with interleukin-2 against murine renal and colon cancers by xanthenone-4-acetic acid derivatives.
Futami H; Eader L; Back TT; Gruys E; Young HA; Wiltrout RH; Baguley BC
J Immunother (1991); 1992 Nov; 12(4):247-55. PubMed ID: 1477076
[TBL] [Abstract][Full Text] [Related]
8. Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice.
Thomsen LL; Ching LM; Zhuang L; Gavin JB; Baguley BC
Cancer Res; 1991 Jan; 51(1):77-81. PubMed ID: 1988109
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide production in endotoxin-resistant C3H/HeJ mice stimulated with flavone-8-acetic acid and xanthenone-4-acetic acid analogues.
Thomsen LL; Ching LM; Joseph WR; Baguley BC; Gavin JB
Biochem Pharmacol; 1992 Jun; 43(11):2401-6. PubMed ID: 1610403
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the ability of DMXAA and xanthenone analogues to activate NF-kappaB in murine and human cell lines.
Woon ST; Reddy CB; Drummond CJ; Schooltink MA; Baguley BC; Kieda C; Ching LM
Oncol Res; 2005; 15(7-8):351-64. PubMed ID: 16491953
[TBL] [Abstract][Full Text] [Related]
11. In vitro methods for screening agents with an indirect mechanism of antitumour activity: xanthenone analogues of flavone acetic acid.
Ching LM; Finlay GJ; Joseph WR; Baguley BC
Eur J Cancer; 1991; 27(12):1684-9. PubMed ID: 1782083
[TBL] [Abstract][Full Text] [Related]
12. Induction of natural killer activity by xanthenone analogues of flavone acetic acid: relation with antitumour activity.
Ching LM; Joseph WR; Zhuang L; Atwell GJ; Rewcastle GW; Denny WA; Baguley BC
Eur J Cancer; 1991; 27(1):79-83. PubMed ID: 1826446
[TBL] [Abstract][Full Text] [Related]
13. Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo.
Rewcastle GW; Atwell GJ; Baguley BC; Calveley SB; Denny WA
J Med Chem; 1989 Apr; 32(4):793-9. PubMed ID: 2704025
[TBL] [Abstract][Full Text] [Related]
14. Potential antitumor agents. 60. Relationships between structure and in vivo colon 38 activity for 5-substituted 9-oxoxanthene-4-acetic acids.
Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
J Med Chem; 1990 May; 33(5):1375-9. PubMed ID: 2329557
[TBL] [Abstract][Full Text] [Related]
15. Modulation of superoxide production from murine macrophages by the antitumour agent flavone acetic acid and xanthenone acetic acid analogues.
Thomsen LL; Baguley BC; Ching LM; Gavin JB
Biochem Pharmacol; 1992 Jan; 43(2):386-9. PubMed ID: 1310856
[No Abstract] [Full Text] [Related]
16. Synthesis and antitumor activity of new derivatives of xanthen-9-one-4-acetic acid.
Gobbi S; Rampa A; Bisi A; Belluti F; Valenti P; Caputo A; Zampiron A; Carrara M
J Med Chem; 2002 Oct; 45(22):4931-9. PubMed ID: 12383019
[TBL] [Abstract][Full Text] [Related]
17. Disposition of the novel antitumour agent xanthenone-4-acetic acid in the mouse: identification of metabolites and routes of elimination.
Kestell P; Rewcastle GW; Baguley BC
Xenobiotica; 1994 Jul; 24(7):635-47. PubMed ID: 7975728
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxic activity of N-[(alkylamino)alkyl]carboxamide derivatives of 7-oxo-7H-benz[de]anthracene, 7-oxo-7H-naphtho[1,2,3-de]quinoline, and 7-oxo-7H-benzo[e]perimidine.
Bu X; Chen J; Deady LW; Smith CL; Baguley BC; Greenhalgh D; Yang S; Denny WA
Bioorg Med Chem; 2005 Jun; 13(11):3657-65. PubMed ID: 15862994
[TBL] [Abstract][Full Text] [Related]
20. Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Tijono SM; Guo K; Henare K; Palmer BD; Wang LC; Albelda SM; Ching LM
Br J Cancer; 2013 Apr; 108(6):1306-15. PubMed ID: 23481185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
